Market Cap | ₹2.71Cr |
ROE | 40.51% |
P/E Ratio(TTM) | -16.07 |
EPS(TTM) | -0.28 |
P/B Ratio | 0.00 |
Dividend Yield | 0.00% |
Industry P/E | 40.50 |
Book Value | -0.55 |
Debt to Equity | -0.75 |
Face Value | 5 |
Parent Organisation | Rekvina Laboratories Limited |
BSE Symbol | 526075 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 61.10 | ||
Gland Pharma | NA (0.00%) | 42.27 | ||
Ajanta Pharma | NA (0.00%) | 33.99 | ||
Eris Lifesciences | NA (0.00%) | 57.15 |